NOS S.G.P.S. S.A. (NOS)
Euronext Lisbon · Portugal · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 5.165 |
|---|---|
| 52-week range | 3.605 – 5.705 |
| Return, 1 month / 3 months | −4.4% / +5.2% |
| Return, 1 year / 3 years | +40.6% / +73.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 44 |
| Volatility (1 year) | 23.6% |
| Worst drawdown (1 year) | -15.2% |
| Average daily value traded | 2.54M EUR |
| Dividend yield | 1.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
NOS S.G.P.S. S.A. is a Portuguese communications and media group based in Lisbon. Through its operating companies it provides mobile and fixed-line telephone services, broadband internet, television and bundled packages to households and business customers across Portugal. The group also runs cinema exhibition and audiovisual content operations, and offers telecommunications services to corporate and wholesale clients. Its brands serve consumers and enterprises throughout the country.
The shares are listed on the Euronext Lisbon in Portugal under the code NOS, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
NOS S.G.P.S. S.A. (NOS) trades on the Euronext Lisbon in Portugal. It last closed at EUR 5.165 on 23 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 10 of 36 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 40.6% and over the last three months it rose 5.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Lisbon
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.1% | ||
| From 52-week high | -8.8% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 5.2% | ||
| 6-month return | -7.2% | ||
| 12-month return, skipping the last month | 47.0% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 23.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.2% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 2.54M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 32 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.9% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.7% |
|---|---|
| 1 month | −4.4% |
| 3 months | +5.2% |
| 6 months | −7.2% |
| 1 year | +40.6% |
| 3 years | +73.5% |
| 5 years | +92.8% |
Signals
| 50-day / 200-day average | 5.175 / 5.060 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.100 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 May 2026 | EUR 0.1000 |
| 22 Apr 2025 | EUR 0.0500 |
| 22 Apr 2024 | EUR 0.3500 |
| 19 Apr 2023 | EUR 0.1520 |
| 5 May 2022 | EUR 0.2780 |
| 4 May 2021 | EUR 0.2780 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Lisbon; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.